Jonathan Anthony Pappas, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3100 Sw 62nd Ave, Miami, FL 33155 Phone: 305-663-8456 Fax: 305-663-8573 |
Dakota Christopher Quinn, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-3621 |
Mr. John Mason Olson, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-1960 |
Harsimar Singh Jassar, AA-C Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 3100 Sw 62nd Ave, Miami, FL 33155 Phone: 305-666-6511 |
Amy Patel, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-1960 |
Courtney Elizabeth Martin, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-3621 |
Giselle Trotti, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-437-2672 Fax: 954-851-1746 |
Michael Cioffi, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-3621 |
News Archive
With the New Year upon us, all over the nation, countless individuals are making new health and fitness resolutions for 2010. Then, in short order, we hear about the masses who don't achieve their goal. Of course, that doesn't have to be the case. New Year's Resolution Success really can become a reality.
Among the populations most significantly affected by COVID-19 are the elderly and patients with preexisting medical conditions including diabetes, hypertension, obesity, metabolic syndrome, cardiovascular disease and chronic lung diseases like COPD and asthma.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has invested in Iwase Dental Supply, Inc., a leading full-service provider of dental consumables, implants and equipment in Japan.
› Verified 2 days ago